Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 103 results.
User Information
Export Records
  1. 1.   Clathrin light chain A drives selective myosin VI recruitment to clathrin-coated pits under membrane tension
  2. Biancospino, Matteo; Buel,Gwen; Niño, Carlos A; Maspero, Elena; di Perrotolo, Rossella Scotto; Raimondi, Andrea; Redlingshöfer, Lisa; Weber, Janine; Brodsky, Frances M; Walters,Kylie; Polo, Simona
  3. Nature communications. 2019, Oct 31; 10(1): 4974.
  1. 2.   Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
  2. Saleh, Anthony D.; Cheng, Hui; Martin, Scott E.; Si, Han; Ormanoglu, Pinar; Carlson, Sophie; Clavijo, Paul E.; Yang, Xinping; Das, Rita; Cornelius, Shaleeka; Couper, Jamie; Chepeha, Douglas; Danilova, Ludmila; Harris, Thomas M.; Prystowsky, Michael B.; Childs, Geoffrey J.; Smith, Richard; Robertson, A. Gordon; Jones, Steven J. M.; Cherniack, Andrew D.; Kim, Sang S.; Rait, Antonina; Pirollo, Kathleen F.; Chang, Esther H.; Chen, Zhong; Van Waes, Carter
  3. CLINICAL CANCER RESEARCH. 2019, MAY 1; 25(9): 2860-2873.
  1. 3.   Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
  2. Nussinov,Ruth; Jang,Hyunbum; Tsai,Chung-Jung; Cheng, Feixiong
  3. PLoS computational biology. 2019, Mar; 15(3):
  1. 4.   Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection
  2. Shirey, Kari Ann; Sunday, Mary E.; Lai, Wendy; Patel, Mira C.; Blanco, Jorge C. G.; Cuttitta,Frank; Vogel, Stefanie N.
  3. Mucosal immunology. 2019, Jan; 12(1): 223-231.
  1. 5.   Cell-free formation and interactome analysis of caveolae
  2. Jung, Wooram; Sierecki, Emma; Bastiani, Michele; O'Carroll, Ailis; Alexandrov, Kirill; Rae, James; Johnston, Wayne; Hunter, Dominic J. B.; Ferguson, Charles; Gambin, Yann; Ariotti, Nicholas; Parton, Robert G.
  3. Journal of Cell Biology. 2018, Jun 04; 217(6): 2141-2165.
  1. 6.   Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers
  2. Kawakami, Masanori; Mustachio, Lisa Maria; Liu, Xi; Dmitrovsky, Ethan
  3. Molecular Cancer Therapeutics. 2018, Apr; 17(4): 724-731.
  1. 7.   The G-Protein-Coupled Chemoattractant Receptor Fpr2 Exacerbates High Glucose-Mediated Proinflammatory Responses of Müller Glial Cells
  2. Yu, Ying; Bao, Zhiyao; Wang, Xiaofei; Gong, Wang; Chen, Hui; Guan, Huaijin; Le, Yingying; Su, Shaobo; Chen, Keqiang; Wang, Jiming
  3. Frontiers in Immunology. 2017, Dec 19; 8: 1852.
  1. 8.   Regulation of inflammation by members of the formyl-peptide receptor family
  2. Chen, Keqiang; Bao, Zhiyao; Gong, Wang; Tang, Peng; Yoshimura, Teizo; Wang, Jiming
  3. JOURNAL OF AUTOIMMUNITY. 2017, DEC; 85: 64-77.
  1. 9.   Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J. R.; Morris, N. L.; Anderson, L. M.
  3. International Journal of Cancer. 2012, Jan; 130(2): 251-258.
  1. 10.   Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart
  2. Hwang, C. J.; Fields, J. R.; Shiao, Y. H.
  3. Cell Death & Disease. 2011, Dec; 2
  1. 11.   RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
  2. Lipkowitz, S.; Weissman, A. M.
  3. Nature Reviews Cancer. 2011, Sep; 11(9): 629-643.
  1. 12.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 13.   Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies
  2. Gursel, D. B.; Connell-Albert, Y. S.; Tuskan, R. G.; Anastassiadis, T.; Walrath, J. C.; Hawes, J. J.; Amlin-Van Schaick, J. C.; Reilly, K. M.
  3. Neuro-Oncology. 2011, Jun; 13(6): 610-621.
  1. 14.   Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas
  2. Kummar, S.; Gutierrez, M. E.; Chen, A.; Turkbey, I. B.; Allen, D.; Horneffer, Y. R.; Juwara, L.; Cao, L.; Yu, Y. K.; Kim, Y. S.; Trepel, J.; Chen, H.; Choyke, P.; Melillo, G.; Murgo, A. J.; Collins, J.; Doroshow, J. H.
  3. European Journal of Cancer. 2011, May; 47(7): 997-1005.
  1. 15.   Regulation of Trafficking of Activated TrkA Is Critical for NGF-Mediated Functions
  2. Yu, T.; Calvo, L.; Anta, B.; Lopez-Benito, S.; Southon, E.; Chao, M. V.; Tessarollo, L.; Arevalo, J. C.
  3. Traffic. 2011, Apr; 12(4): 521-534.
  1. 16.   Peptide Structure Stabilization by Membrane Anchoring and its General Applicability to the Development of Potent Cell-Permeable Inhibitors
  2. Johannessen, L.; Remsberg, J.; Gaponenko, V.; Adams, K. M.; Barchi, J. J.; Tarasov, S. G.; Jiang, S.; Tarasova, N. I.
  3. Chembiochem. 2011, Apr; 12(6): 914-921.
  1. 17.   Genetic Inactivation of ERK1 and ERK2 in Chondrocytes Promotes Bone Growth and Enlarges the Spinal Canal
  2. Sebastian, A.; Matsushita, T.; Kawanami, A.; Mackem, S.; Landreth, G. E.; Murakami, S.
  3. Journal of Orthopaedic Research. 2011, Mar; 29(3): 375-379.
  1. 18.   CCAAT/Enhancer-Binding Proteins (C/EBP)-alpha and -beta Are Essential for Ovulation, Luteinization, and the Expression of Key Target Genes
  2. Fan, H. Y.; Liu, Z. L.; Johnson, P. F.; Richards, J. S.
  3. Molecular Endocrinology. 2011, Feb; 25(2): 253-268.
  1. 19.   miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling Pathways
  2. Saydam, O.; Senol, O.; Wurdinger, T.; Mizrak, A.; Ozdener, G. B.; Stemmer-Rachamimov, A. O.; Yi, M.; Stephens, R. M.; Krichevsky, A. M.; Saydam, N.; Brenner, G. J.; Breakefield, X. O.
  3. Cancer Research. 2011, Feb; 71(3): 852-861.
  1. 20.   Back to the Future: Proceedings From the 2010 NF Conference
  2. Huson, S. M.; Acosta, M. T.; Belzberg, A. J.; Bernards, A.; Chernoff, J.; Cichowski, K.; Evans, D. G.; Ferner, R. E.; Giovannini, M.; Korf, B. R.; Listernick, R.; North, K. N.; Packer, R. J.; Parada, L. F.; Peltonen, J.; Ramesh, V.; Reilly, K. M.; Risner, J. W.; Schorry, E. K.; Upadhyaya, M.; Viskochil, D. H.; Zhu, Y. A.; Hunter-Schaedle, K.; Giancotti, F. G.
  3. American Journal of Medical Genetics Part A. 2011, Feb; 155A(2): 307-321.
  1. 21.   Role of IKK alpha in skin squamous cell carcinomas
  2. Park, E. M.; Liu, B. G.; Xia, X. J.; Zhu, F.; Jami, W. B.; Hu, Y. L.
  3. Future Oncology. 2011, Jan; 7(1): 123-134.
  1. 22.   The odyssey of marine pharmaceuticals: a current pipeline perspective
  2. Mayer, A. M. S.; Glaser, K. B.; Cuevas, C.; Jacobs, R. S.; Kem, W.; Little, R. D.; McIntosh, J. M.; Newman, D. J.; Potts, B. C.; Shuster, D. E.
  3. Trends in Pharmacological Sciences. 2010, Jun; 31(6): 255-265.
  1. 23.   Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells
  2. Moody, T. W.; Switzer, C.; Santana-Flores, W.; Ridnour, L. A.; Berna, M.; Thill, M.; Jensen, R. T.; Sparatore, A.; Del Soldato, P.; Yeh, G. C.; Roberts, D. D.; Giaccone, G.; Wink, D. A.
  3. Lung Cancer. 2010, May; 68(2): 154-160.
  1. 24.   Inheritance of susceptibility to induction of nephroblastomas in the Noble rat
  2. Diwan, B. A.; Timofeeva, O.; Rice, J. M.; Yang, Y. L.; Sharma, N.; Fortini, M. E.; Wang, H. H.; Perantoni, A. O.
  3. Differentiation. 2009, Apr; 77(4): 424-432.
  1. 25.   A tale of terminal differentiation IKK alpha, the master keratinocyte regulator
  2. Liu, B. G.; Zhu, F.; Xia, X. J.; Park, E.; Hu, Y. L.
  3. Cell Cycle. 2009 8(4): 527-531.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel